---
figid: PMC9644706__10020_2022_560_Fig3_HTML
figtitle: FADD as a key molecular player in cancer progression
organisms:
- Mus musculus
- Rattus norvegicus
- Adenoviridae
- Homo sapiens
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9644706
filename: 10020_2022_560_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9644706/figure/Fig3/
number: F3
caption: Role of FADD in cancer progression. FADD dysregulation contributes to cancer
  progression by various mechanisms, including crosstalk with oncogenic signaling
  pathway, induction of inflammation, inhibition of apoptosis, promotion of proliferation,
  modulation of cell cycle, and enhancement of drug resistance
papertitle: FADD as a key molecular player in cancer progression.
reftext: Ying Liu, et al. Mol Med. 2022;28:132.
year: '2022'
doi: 10.1186/s10020-022-00560-y
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: BioMed Central
keywords: FADD | Inflammation | Drug resistance | Biomarker | Therapeutic target
automl_pathway: 0.9449469
figid_alias: PMC9644706__F3
figtype: Figure
redirect_from: /figures/PMC9644706__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9644706__10020_2022_560_Fig3_HTML.html
  '@type': Dataset
  description: Role of FADD in cancer progression. FADD dysregulation contributes
    to cancer progression by various mechanisms, including crosstalk with oncogenic
    signaling pathway, induction of inflammation, inhibition of apoptosis, promotion
    of proliferation, modulation of cell cycle, and enhancement of drug resistance
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FADD
  - WARS1
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - AN
  - BCL2
  - Fadd
  - Gabrg2
  - Mapk8
  - Nfkb1
  - Ephb2
  - Mapk1
  - Bcl2
  - CycE
  - cyc
  - fo
  - anon-70Dc
  - LanB2
  - anon-70Db
  - bsk
  - Dif
  - dl
  - Rel
  - Erk7
  - rl
  - an
  - Debcl
---
